Google News

B

Biontech

BioNTech to wind down cell therapy manufacturing in Maryland, lay off 63 as it ends development of CAR-T drug in testicular cancer

Jun 18

By Fraiser Kansteiner

BioNTech takes over CureVac in $1.25 billion all-stock deal among COVID rivals

Jun 12

By Ludwig Burger

News about Genmab

Genmab and BioNTech’s Promising Immunoradiotherapy Study for Metastatic Tumors

10 hours ago

Genmab and BioNTech’s GEN1056 Study: A Potential Game-Changer in Oncology

10 hours ago

Genmab’s GEN1057 Trial: A New Hope for Cancer Treatment?

11 hours ago

Genmab’s GEN1107 Study: A New Hope for Advanced Solid Tumors

11 hours ago

Genmab’s GEN1047 Trial: A New Hope for Solid Tumor Treatment

11 hours ago

Full Coverage of this story

Bristol Myers agrees up to $11.1 billion deal with BioNTech to shake up cancer immunotherapy

Jun 2

By Michael Erman & Ludwig Burger

CureVac Joins BioNTech: €1.25B Deal Marks New Era in mRNA

Jun 13

BioNTech (BNTX) Awaits Potential Vaccine Ingredient Review | BNT

Jun 18

DirectorsTalk Interviews

BioNTech SE (BNTX) Stock Analysis: Exploring A 23.72% Potential Upside Amidst Challenging Financial Metrics

Jun 9

FDA Asks Pfizer/BioNTech, Moderna To Add Myocarditis Risk to COVID-19 Vaccines

May 22

By Tristan Cesar Manalac

Biontech SE’s BNT317 Study: A New Hope for Advanced Solid Tumors

Jun 30

European Pharmaceutical Review

BioNTech pledges major UK investment

May 21

Alnylam drops Covid vaccine patent case against Pfizer, BioNTech for now

May 14

By Blake Brittain

BioNTech SE (BNTX) Q1 2025 Earnings Call Highlights: Navigating Challenges and Advancing ...

May 6

BioNTech SE: Hold Rating Amid Mixed Clinical Trial Results for BNT327

Jun 1

BioNTech works to diversify supply base ahead of oncology launch

May 5

By Eric Sagonowsky

BioNTech SE (BNTX): Among the Best Growth Stocks to Buy and Hold for the Long Term

May 13

BioNTech says Novartis executive Zapata-Gomez to become CFO

May 5

Investor's Business Daily

BioNTech Surges On Summit's Coattails. But Can They Take On Merck?

Apr 23

By Allison Gatlin

Backing from BioNTech powers ADC specialist DualityBio toward $200M Hong Kong IPO

Apr 7

Crowell & Moring LLP

USPTO Finds Claims of Two of Moderna's mRNA Patents Unpatentable: What's Next in the Vaccine Wars?

Mar 24

BioNTech SE’s Promising Study on Pancreatic Cancer Treatment: What Investors Need to Know

Jun 26

BioNTech SE (NASDAQ:BNTX) Analysts Just Slashed This Year's Estimates

Mar 16

BioNTech passes on Autolus' CAR-T amid pipeline prioritization

Mar 20

CureVac Wins Key mRNA Patent Battle Against BioNTech in Europe | CVAC Stock News

Mar 27

Why BioNTech Stock Got Trounced on Tuesday

May 6

By Eric Volkman

BioNTech SE Announces Virtual Annual General Meeting for 2025

Apr 4

FirstWord Pharma

BioNTech's PD-L1/VEGF-A impresses in SCLC as bispecific battle heats up

Mar 28

By Elizabeth Eaton

Is BioNTech SE (BNTX) a Promising Biotech Stock According to Wall Street Analysts

Mar 25

Health Rounds: Roche/BioNTech experimental vaccine shows early promise in pancreatic cancer

Mar 5

By Nancy Lapid

BioNTech Stock Drops as Sales Outlook Disappoints

Mar 10

By Nisha Gopalan

BioNTech's Pivot Into Oncology Still Makes It A Compelling Investment (NASDAQ:BNTX)

Mar 17

By Myriam Alvarez

Moderna and Freshfields triumph in Düsseldorf against BioNTech and Pfizer

Mar 5

By Mathieu Klos

FDA Pauses BioNTech's Malaria Vaccine Trial Amid Broader Vaccine Challenges

Mar 5

By Sophia Abene

BioProcess International

BioNTech on how Biotheus buy delivers antibody production capabilities

Mar 17

By Dan Stanton

BioNTech SE (NASDAQ:BNTX) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Mar 13

Anadolu Ajansı

BioNTech posts $721M loss in 2024 due to low demand for COVID-19 vaccines

Mar 10

US FDA lifts partial clinical hold on BioNTech cancer drug study

Dec 13, 2024

By Sriparna Roy

Promising BioNTech data on triple negative breast cancer treatment

Dec 10, 2024

By Angus Chen

BioNTech Strives to Become Commercial 'Powerhouse' While Maintaining Humility

Jan 16

By Annalee Armstrong

BioNTech Q3 Earnings Review: Good Quarter, Strong Promise — But Still A Hold (NASDAQ:BNTX)

Nov 6, 2024

By Edmund Ingham

BioNTech SE Updates Articles of Association to Boost Financial Flexibility

Jun 17

Pharmaceutical Technology

BioNTech signs agreement to acquire Biotheus

Nov 14, 2024

JPM25 Day One: Pfizer, BioNTech, Moderna and More Present Pipeline Updates

Jan 14

By Dan Samorodnitsky

Financial Times

DeepMind and BioNTech build AI lab assistants for scientific research

Oct 1, 2024

By Ian Johnston & Madhumita Murgia

How BioNTech’s "revolutionary" lung cancer vaccine actually works

Dec 12, 2024

By Tim Brinkhof

BioNTech ends work on Genmab-partnered bispecific antibody acasunlimab

Aug 5, 2024

By James Waldron

Triastek Announces Research Collaboration and Platform Technology License Agreement with BioNTech to Advance 3D Printed Oral RNA Therapeutics

Jul 23, 2024

BioNTech Stock: Lackluster Financials And Uncertainties In Product Pipeline - Hold (BNTX)

Jan 23

Ovarian cancer: BioNTech, Curelab, OvarianVax and more bring vaccines to the clinic

Dec 17, 2024

By Roohi Mariam Peter

Pfizer, BioNTech Covid-Flu Combination Shot Misses on Trial Goal

Aug 16, 2024

By Damian Garde

BioNTech enters settlement with US agency, UPenn over COVID vaccine royalties

Dec 27, 2024

The Motley Fool

3 No-Brainer Biotech Stocks to Buy With $200 Right Now

Dec 18, 2024

By Keith Speights

flow – Deutsche Bank

How BioNTech masters real-time treasury

Jul 10, 2024

Biontech: Research cooperation with US company BMS

Jun 3

BioNTech and Moderna: A tale of two mRNA developers (BNTX:NASDAQ)

Oct 18, 2024

By Jonathan Block, MPH

Case report: Development of anxiety symptoms after receiving the Pfizer-BioNTech (BNT162b2) COVID-19 vaccine: a case series

Jan 21

BioNTech counts on shift to cancer drugs after second quarter losses quadruple

Aug 5, 2024

By Rachel More, Miranda Murray & Susan Fenton

The Globe and Mail

Berenberg Bank Sticks to Their Buy Rating for BioNTech SE (BNTX)

May 7

BioNTech Is More Than a Covid-19 Stock. It’s Having a Great September.

Sep 19, 2024

By Josh Nathan-kazis

Pfizer, BioNTech win bid to invalidate CureVac's UK COVID vaccine patents

Oct 8, 2024

By Sarah Young, Sam Tobin & Sachin Ravikumar

Clinical Trials Arena

BioNTech initiates global trials of mRNA-based lung cancer vaccine

Aug 26, 2024

Exploring the adverse events of Oxford–AstraZeneca, Pfizer-BioNTech, Moderna, and Johnson and Johnson COVID-19 vaccination on Guillain–Barré Syndrome | Scientific Reports

Aug 13, 2024

Can BioNTech sustain a post-COVID mRNA pipeline? Oncology is the next hope.

Aug 14, 2024

By Amy Baxter

The Daily Pennsylvanian

Penn sues BioNTech, seeks ‘full royalty payments’ for COVID-19 vaccine

Aug 12, 2024

By Isaac Pollock

BioNTech, Regeneron's mRNA Cancer Vaccine Combo Clears Phase II in Melanoma

Jul 30, 2024

By Tristan Cesar Manalac

BioNTech Hit with NIH Notice of Default Over COVID-19 Vaccine Royalties

Mar 26, 2024

By Tristan Cesar Manalac

BioMelbourne Network

BioForum – BioNTech: From concept to clinical trials

Nov 28, 2024

Search

Clear search

Close search

Google apps

Main menu